Zomedica Corp. (ZOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0454
+0.0014 (3.30%)
Jun 5, 2025, 9:30 AM EDT
Zomedica Revenue
Zomedica had revenue of $6.50M in the quarter ending March 31, 2025, with 3.80% growth. This brings the company's revenue in the last twelve months to $27.52M, up 6.00% year-over-year. In the year 2024, Zomedica had annual revenue of $27.29M with 8.33% growth.
Revenue (ttm)
27.52M
Revenue Growth
+6.00%
P/S Ratio
1.57
Revenue / Employee
181.07K
Employees
152
Market Cap
43.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| American Oncology Network | 1.76B |
Zomedica News
- 15 days ago - Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution - Accesswire
- 16 days ago - Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations - Accesswire
- 20 days ago - Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth - Accesswire
- 23 days ago - Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy - Accesswire
- 27 days ago - Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET - Accesswire
- 2 months ago - Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - Accesswire
- 3 months ago - Zomedica Corp. Announces Transition to OTCQB Venture Market - Accesswire